Drugs / LEXANERSEN
LEXANERSEN
also known as
WVE-120102 · BMTR-5149 · BMTR-5149 FREE ACID · BMTR5149 SODIUM · LEXANERSEN SODIUM · WV-2603 · WV-2603 FREE ACID · WV-2603 SODIUM · +2 more
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04617860 | Sep 2019 → Apr 2021 | Huntington disease | Wave Life Sciences USA, Inc. | Terminated | No outcome recorded |
| Phase 1/2 | NCT03225846 | Jul 2017 → May 2021 | Huntington disease | Wave Life Sciences USA, Inc. | Terminated | No outcome recorded |
Evidence & citations 13 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LEXANERSEN | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650262 ↗ |
| Known as | BMTR-5149 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650262 ↗ |
| Known as | BMTR-5149 FREE ACID | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650262 ↗ |
| Known as | BMTR5149 SODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650262 ↗ |
| Known as | LEXANERSEN SODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650262 ↗ |
| Known as | WV-2603 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650262 ↗ |
| Known as | WV-2603 FREE ACID | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650262 ↗ |
| Known as | WV-2603 SODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650262 ↗ |
| Known as | WVE-120102 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03225846 ↗ |
| Known as | WVE-120102 FREE ACID | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650262 ↗ |
| Known as | WVE-120102 SODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650262 ↗ |
| Modality | Antisense oligonucleotide | “stereopure antisense oligonucleotide (ASO)” NCT03225846 ↗ |
| Route | Intrathecal | “Administered Intrathecally” NCT03225846 ↗ |